Related Experiment Video

Updated: Jun 3, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Clinical applications of miRNAs in cardiac remodeling and heart failure

Veli K Topkara1, Douglas L Mann

  • 1Center for Cardiovascular Research, Division of Cardiology, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.

Personalized Medicine
|March 15, 2011
PubMed

Insights

MicroRNAs (miRNAs) are small RNAs regulating gene expression. This review explores their crucial role in heart failure pathogenesis and cardiac remodeling, highlighting potential therapeutic applications.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • MicroRNAs (miRNAs) are short, noncoding RNAs regulating gene expression post-transcriptionally.
  • miRNAs influence mRNA translation and degradation.
  • Cardiac remodeling involves adaptive and maladaptive changes in heart structure and function.

Purpose of the Study:

  • To review the role of miRNAs in the pathogenesis of heart failure.
  • To explore how miRNAs modulate cardiac remodeling processes.
  • To discuss potential therapeutic applications of miRNA biology in heart failure.

Main Methods:

  • Literature review of miRNA function in cardiac remodeling.
  • Analysis of miRNA involvement in heart failure.
  • Synthesis of current research on miRNA-based therapies for heart failure.

Main Results:

  • miRNAs are key regulators of genes involved in cardiac remodeling.
  • Dysregulation of specific miRNAs contributes to heart failure development.
  • miRNAs offer potential as diagnostic biomarkers and therapeutic targets for heart failure.

Conclusions:

  • miRNAs play a significant role in the complex mechanisms of heart failure.
  • Targeting miRNA pathways presents a promising avenue for novel heart failure treatments.
  • Further research into miRNA biology is essential for advancing cardiovascular medicine.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...